Deal Summary
On January 2, 2025, the U.S. International Development Finance Corporation (DFC) announced a $1 million loan investment in Ilara Health Limited (Ilara Health), a Kenya-based company specialising in medical products and solutions. Ilara Health provides diagnostic devices, health management technology, and pharmaceutical products to peri-urban and rural clinics and pharmacies. The investment will help Ilara Health support private outpatient clinics in Kenya, delivering care to underserved communities with essential portable diagnostic devices and pharmaceutical products. This loan follows a $4.2 million debt-equity pre-Series A round in 2024 led by DOB Equity, with participation from Philips Foundation, AAIC Investment, Angaza Capital, Black Pearl Investments, Perivoli Innovations, Alphamundi, Kiva Capital, and Boehringer Ingelheim.
Terms
- Fund Manager: U.S. International Development Finance Corporation
- Target: Ilara Health Limited
- Financing Type: Debt
- Investment Strategy: Venture debt
- Amount: $1 million
Deal Rationale
With over 500 million Africans unable to access basic tests like blood analyses, this investment aligns with DFC’s
